Plain-English translation of NCT06401889 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at how Aromatase Inhibitor therapy (a hormone medication commonly given to breast cancer survivors) affects skin quality and how you feel about your appearance. Researchers will measure any skin changes using special photography and imaging technology, and then offer personalized skincare consultations with a professional aesthetician to see if that helps improve both your skin and your confidence.
Many people taking this medication notice changes in their skin, but there hasn't been much research on how common this is or what can actually help. This trial aims to understand the problem better and find practical solutions that improve both skin health and quality of life during treatment.
You likely qualify if…
You likely don't qualify if…
You will complete survey questionnaires about how you feel about your skin and appearance, have your skin photographed and measured using specialized imaging technology, and attend a consultation with a skincare professional. After the initial assessment, you'll receive personalized skincare recommendations, then return for follow-up measurements and surveys to see if the skincare plan helps improve both your skin and how you feel.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
United States
Sponsor
Mayo Clinic
Enrollment target
~35 participants
Started
July 2024
Primary completion
July 2027
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clinical Trials Referral Office
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.